Navigation Links
Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
Date:9/5/2008

tigenic sequence has been identified, such as infectious, parasitic, malignant or autoimmune diseases and allergies, are potential therapeutic or preventive sites for the application of L.E.A.P.S.(TM) technology.

The concept behind the L.E.A.P.S.(TM) technology is to directly mimic cell/cell interactions on the T-cell surface with synthetic peptides. The L.E.A.P.S.(TM) constructs containing the antigenic disease epitope linked to a T-cell binding ligand (TCBL) can be manufactured by peptide synthesis or by covalently linking the two peptides. Depending upon the type of L.E.A.P.S.(TM) construct and TCBL used, CEL-SCI is able to direct the outcome of the immune response towards the development of T-cell function with primarily effector T-cell functions (T Lymphocyte; helper/effector T lymphocyte, type 1 or 2 [Th1 or Th2], cytotoxic [Tc] or suppressor [Ts]). Therefore, it would appear that the L.E.A.P.S.(TM) construct represents a chimeric peptide with bi-functional behavior.

About CEL-SCI:

CEL-SCI Corporation is developing products that empower immune defenses. Its lead product is Multikine(R). In Phase II clinical trials, Multikine was shown to be safe and well tolerated, and to improve the patients' overall survival by 33% at a median of three and a half years following surgery. The U.S. Food and Drug Administration (FDA) gave the go-ahead for a Phase III clinical trial with Multikine in January 2007 and granted orphan drug status to Multikine in the neoadjuvant therapy of squamous cell carcinoma (cancer) of the head and neck in May 2007.

The Company has operations in Vienna, Virginia, and Baltimore, Maryland. CEL-SCI's other products, which are currently in pre-clinical stage, have shown protection against a number of diseases in animal tests and are being tested against diseases associated with bio-defense and avian flu.

When used in this report, the words "intends," "believes," "anticipated" and "expects" and similar expressions
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
3. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
4. Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
5. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
6. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
7. Pharmacokinetic Data Suggest NGX426, TorreyPines Therapeutics Oral Prodrug of Tezampanel, May be Effective in Treating Acute Migraine Headache
8. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
9. Recent Studies Suggest Popular Diet Pill Relacore Reduces Acne Breakouts
10. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
11. New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015  Sarnova, parent company ... of the new www.tri-anim.com website, continuing ... healthcare distributor of respiratory, anesthesia and other critical ... The site has many new features ... making online shopping and ordering easier and more ...
(Date:3/2/2015)... , March 2, 2015  Tandem Diabetes Care®, Inc. ... and manufacturer of the t:slim® and t:flex™ Insulin Pumps, ... public offering of common stock have exercised their option ... stock at a price to the public of $11.50 ... offering is expected to be $64.8 million, after deducting ...
(Date:3/2/2015)... SOUTH SAN FRANCISCO, Calif. , March 2, ... therapeutics for the treatment of cancer, today announced ... comprised of leading researchers and clinicians in the ... The new advisory boards will ... its wholly owned pipeline of precision immunotherapies and ...
Breaking Medicine Technology:Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 2Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 3Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 3CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 3
... Sept. 13, 2011 Kremers Urban Pharmaceuticals Inc. is ... dismissing all pending litigation arising from its Abbreviated New ... hydrochloride product, for which Concerta® is the reference listed ... The settlement includes a patent license ...
... Pharmaceuticals, Inc. (Nasdaq: SVNT ) today announced that ... will present at the Sixth Annual JMP Securities Healthcare Conference ...  The conference will be held at the St. Regis hotel ... the presentation can be accessed through the investor relations section ...
Cached Medicine Technology:Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference 2
(Date:3/3/2015)... (PRWEB) March 03, 2015 Aurora Fit ... celebration and charity drive to observe the opening of the ... charity organization Ashleigh’s Hope. The event will be held on ... S #7, Aurora, ON. The opening will feature free boot ... Fit Body Boot Camp is the world’s most popular and ...
(Date:3/2/2015)... Formetco today announced the official launch ... FTX uses state-of-the-art technology to deliver an outdoor advertising ... satisfaction. An item of particular value, and previously ... year LED Brightness Warranty. , Why the FTX was ... billboard among any other billboard product in the world. ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Dr. David ... injury, is partnering with Doctors on Liens ... patients. It’s rare for personal injury victims to ... and especially on a lien basis. However, San ... outstanding team of chiropractors, M.D., pain management physician, massage, ...
(Date:3/2/2015)... New York, NY (PRWEB) March 02, 2015 ... a long history of catalyzing private sector activities ... that it has recently elected four new members ... , GBCHealth welcomes Dr. Paul Farmer, Chief Strategist ... University Professor at Harvard University; Dr. Huma Abbasi, ...
(Date:3/2/2015)... 02, 2015 “ Wants and Needs ... monthly AppWatch, which features the latest and coolest mobile ... Tropeano, a mobile technology expert and host of NewsWatch, ... this app helps people evaluate priorities. , Whether a ... Wants and Needs app. The app allows people to ...
Breaking Medicine News(10 mins):Health News:Aurora Fit Body Boot Camp Celebrates Grand Opening with Charity Fundraiser 2Health News:Aurora Fit Body Boot Camp Celebrates Grand Opening with Charity Fundraiser 3Health News:Formetco Launches Innovative LED Billboard System 2Health News:Distinguished Doctor Brings His Multi-Specialty Medical Group to Doctors on Liens in San Diego 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2
... Recent researcher has shown that there is no link ... over the past few years has suggested vaccinations that ... polio, diphtheria and other diseases might be putting children ... ,Studies have shown countries where childhood vaccinations are ...
... coronavirus. Similar viruses infect the pigs and other animals. It ... more than two dozen countries on four continents before it ... were sickened, and at least 774 died.Civet cats and other ... southern China are suspected of spreading SARS to humans although ...
... exercising and the prevention and survival rates of certain ... results from nearly 850 women with endometrial cancer, aged ... of exercise activity during their adolescent and adult years.Results ... life were up to 40 percent less likely to ...
... Latest researcher show that a few alcoholic beverages a ... disease in men // with high blood pressure. ... had a significantly lower risk of death by nearly ... a reduced risk of cardiovascular disease death as alcohol ...
... cancer patients by 63 percent with their latest drug ... trial strengthens the case for administering the newer drug, ... women recovering from breast cancer lowered their chance of ... to exemestane after two or three years of tamoxifen ...
... Sports and Exercise and the Center for Asthma and Allergy Care, ... 18-year olds who had at least one risk factor for asthma. ... risk factor noted by children was a family member having allergies ... 10 minutes. Forced expiratory volume ( FEV ) was measured at ...
Cached Medicine News:Health News:SARS vaccine shows promise in Animal Testing 2
TG (Ab) RIA Thyroid Function 014-HD 27.1 Thyroglobulin...
... test kit is a solid phase enzyme ... is designed for the quantitative measurement of ... serum or plasma. The microplate is coated ... and patient samples are pipetted into the ...
Free T3 EIA Thyroid Function 025-BC-1006...
Prolactin EIA Reproductive Markers 025-BC-1037...
Medicine Products: